These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 23095848)
1. Reducing available soluble β-amyloid prevents progression of cerebral amyloid angiopathy in transgenic mice. Gregory JL; Prada CM; Fine SJ; Garcia-Alloza M; Betensky RA; Arbel-Ornath M; Greenberg SM; Bacskai BJ; Frosch MP J Neuropathol Exp Neurol; 2012 Nov; 71(11):1009-17. PubMed ID: 23095848 [TBL] [Abstract][Full Text] [Related]
2. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340 [TBL] [Abstract][Full Text] [Related]
3. Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. Robbins EM; Betensky RA; Domnitz SB; Purcell SM; Garcia-Alloza M; Greenberg C; Rebeck GW; Hyman BT; Greenberg SM; Frosch MP; Bacskai BJ J Neurosci; 2006 Jan; 26(2):365-71. PubMed ID: 16407531 [TBL] [Abstract][Full Text] [Related]
4. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice. Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613 [TBL] [Abstract][Full Text] [Related]
5. Cerebral amyloid angiopathy: an overview. Yamada M Neuropathology; 2000 Mar; 20(1):8-22. PubMed ID: 10935432 [TBL] [Abstract][Full Text] [Related]
13. Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Hartz AM; Bauer B; Soldner EL; Wolf A; Boy S; Backhaus R; Mihaljevic I; Bogdahn U; Klünemann HH; Schuierer G; Schlachetzki F Stroke; 2012 Feb; 43(2):514-23. PubMed ID: 22116809 [TBL] [Abstract][Full Text] [Related]
14. Fruquintinib/HMPL-013 ameliorates cognitive impairments and pathology in a mouse model of cerebral amyloid angiopathy (CAA). Zhou G; Xiang T; Xu Y; He B; Wu L; Zhu G; Xie J; Yao L; Xiao Z Eur J Pharmacol; 2023 Jan; 939():175446. PubMed ID: 36470443 [TBL] [Abstract][Full Text] [Related]
15. Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy. Han BH; Zhou ML; Vellimana AK; Milner E; Kim DH; Greenberg JK; Chu W; Mach RH; Zipfel GJ Mol Neurodegener; 2011 Dec; 6():86. PubMed ID: 22192811 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immunotherapy. Beckmann N; Gérard C; Abramowski D; Cannet C; Staufenbiel M J Neurosci; 2011 Jan; 31(3):1023-31. PubMed ID: 21248127 [TBL] [Abstract][Full Text] [Related]
17. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways. Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379 [TBL] [Abstract][Full Text] [Related]
18. Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity. Bales KR; O'Neill SM; Pozdnyakov N; Pan F; Caouette D; Pi Y; Wood KM; Volfson D; Cirrito JR; Han BH; Johnson AW; Zipfel GJ; Samad TA Brain; 2016 Feb; 139(Pt 2):563-77. PubMed ID: 26493635 [TBL] [Abstract][Full Text] [Related]